Only three companies in the S&P 500 have seen 2028 revenue estimates rise by more than 20% since the end of June. They all ...

Oracle's stock just surged 30% overnight as Wall Street realizes this isn't your father's database company anymore.

Oracle is rated a strong buy with a $530 price target, driven by rapid growth in cloud and AI-related remaining performance ...

Oracle's current P/E ratio of 75x is 143% above its five-year average, signaling overvaluation. Click here to find out why ...

Oracle has introduced new AI-powered features in its Fusion Cloud Applications aimed at helping healthcare organizations strengthen supply chain operations. The enhancements include Oracle Fusion ...

Oracle Health introduced a suite of artificial intelligence-based tools aimed at improving coordination and reducing administrative burden between healthcare providers and payers. The company ...